Annual ROE
84.78%
+82.74%+4055.88%
December 31, 2022
Summary
- As of February 9, 2025, MTAC annual return on equity is 84.78%, with the most recent change of +82.74% (+4055.88%) on December 31, 2022.
Performance
MTAC ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-1.81%
-3.65%-198.37%
June 30, 2023
Summary
- As of February 9, 2025, MTAC quarterly return on equity is -1.81%, with the most recent change of -3.65% (-198.37%) on June 30, 2023.
- Over the past year, MTAC quarterly ROE has dropped by -6.07% (-142.49%).
Performance
MTAC Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MTAC ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4055.9% | -142.5% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MTAC ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -97.6% | -142.5% | at low |
| 5 y | 5-year | at high | -97.6% | -142.5% | >+9999.0% |
| alltime | all time | at high | -97.6% | -142.5% | >+9999.0% |
MedTech Acquisition ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | -1.81%(-198.4%) |
| Mar 2023 | - | 1.84%(-40.3%) |
| Dec 2022 | 84.78% | 3.08%(-17.0%) |
| Sep 2022 | - | 3.71%(-12.9%) |
| Jun 2022 | - | 4.26%(+23.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 3.44%(+66.2%) |
| Dec 2021 | 2.04% | 2.07%(+305.9%) |
| Sep 2021 | - | 0.51%(-210.9%) |
| Jun 2021 | - | -0.46%(-51.6%) |
| Mar 2021 | - | -0.95%(-100.0%) |
| Dec 2020 | - | -2964.17% |
FAQ
- What is MedTech Acquisition annual return on equity?
- What is the all time high annual ROE for MedTech Acquisition?
- What is MedTech Acquisition annual ROE year-on-year change?
- What is MedTech Acquisition quarterly return on equity?
- What is the all time high quarterly ROE for MedTech Acquisition?
- What is MedTech Acquisition quarterly ROE year-on-year change?
What is MedTech Acquisition annual return on equity?
The current annual ROE of MTAC is 84.78%
What is the all time high annual ROE for MedTech Acquisition?
MedTech Acquisition all-time high annual return on equity is 84.78%
What is MedTech Acquisition annual ROE year-on-year change?
Over the past year, MTAC annual return on equity has changed by +82.74% (+4055.88%)
What is MedTech Acquisition quarterly return on equity?
The current quarterly ROE of MTAC is -1.81%
What is the all time high quarterly ROE for MedTech Acquisition?
MedTech Acquisition all-time high quarterly return on equity is 4.26%
What is MedTech Acquisition quarterly ROE year-on-year change?
Over the past year, MTAC quarterly return on equity has changed by -6.07% (-142.49%)